Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode

在首次精神分裂症发作后通过锻炼加强认知训练

基本信息

项目摘要

ABSTRACT This R01 application involves a confirmatory efficacy clinical trial of our innovative treatment approach to improving cognition in schizophrenia, using an experimental therapeutic design that NIMH has advocated. Our intervention approach combines neurotrophin-releasing aerobic exercise training with neuroplasticity-based cognitive training to enhance the impact of cognitive training on cognition and functional outcome. Both cognitive training and exercise address the NIMH strategic research priorities for creating innovative interventions that can be “disseminated broadly” and “readily taught to the existing workforce with minimal cost.” Cognitive remediation and physical exercise have each been shown separately to have promise for improving cognitive deficits in schizophrenia, but used separately yield moderate effects in chronic schizophrenia patients. We will use brain-derived neurotrophic factor (BDNF) as our target and cognition and functional outcome as our clinical outcomes. We hypothesize that the increases in BDNF associated with regular aerobic exercise provide a platform which allows neuroplasticity-based cognitive training to enhance cognition to a greater degree than is typically observed in studies of cognitive training alone. We hypothesize that combining physical exercise with cognitive training will produce larger cognitive and functional improvements, relative to cognitive training alone. This confirmatory efficacy clinical trial is guided by evidence from our current R34 pilot randomized controlled trial comparing the combined treatment with cognitive training without physical exercise. We find compelling evidence of BDNF target engagement, differential improvement in cognition and functional outcome, and prediction of later outcome from initial BDNF gain that strongly supports the movement to a fully powered confirmatory efficacy clinical trial. Cognitive deficits in persons with schizophrenia present an enormous challenge to successful return to functioning in the community. We target the period shortly after a first episode of schizophrenia to maximize the generalization of cognitive improvement to real-world functional outcome, before chronic disability is established. The cognitive training plus aerobic exercise intervention has the potential to examine a hypothesized mechanism of action and to make a meaningful difference in the lives of individuals with severe mental illness.
摘要 该R01申请涉及我们的创新治疗方法的确证性疗效临床试验, 改善精神分裂症的认知,使用NIMH倡导的实验性治疗设计。我们 干预方法结合神经营养素释放有氧运动训练与神经可塑性为基础的 认知训练,以增强认知训练对认知和功能结果的影响。两 认知训练和练习解决了NIMH战略研究的优先事项, 干预措施可以“广泛传播”和“容易地教给现有的劳动力, 成本。”认知补救和体育锻炼分别被证明有希望 改善精神分裂症的认知缺陷,但单独使用在慢性精神分裂症中产生中度效果。 精神分裂症患者我们将以脑源性神经营养因子(BDNF)为靶点, 功能结果作为我们的临床结果。我们假设,BDNF的增加与 定期的有氧运动提供了一个平台,允许基于神经可塑性的认知训练, 认知能力的提高程度要比单纯的认知训练研究中通常观察到的要高。我们假设 将体育锻炼与认知训练相结合, 相对于单独的认知训练,本确证性疗效临床试验以证据为指导 从我们目前的R34试点随机对照试验比较了认知训练的联合治疗, 没有体育锻炼。我们发现了令人信服的证据,BDNF靶点参与,差异改善, 在认知和功能结果方面,以及从最初BDNF获得的后期结果的预测, 支持向充分把握度的确证性疗效临床试验的转变。认知功能障碍 精神分裂症对成功恢复社区功能提出了巨大挑战。我们针对 精神分裂症第一次发作后不久的一段时间,以最大限度地概括认知 在确定慢性残疾之前,改善真实世界的功能结果。认知训练 加上有氧运动干预有可能检查假设的作用机制, 对患有严重精神疾病的人的生活产生有意义的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KEITH H NUECHTERLEIN其他文献

KEITH H NUECHTERLEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KEITH H NUECHTERLEIN', 18)}}的其他基金

Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
在首次精神分裂症发作后通过远程医疗有氧运动和认知训练提高认知能力
  • 批准号:
    10647268
  • 财政年份:
    2023
  • 资助金额:
    $ 90.37万
  • 项目类别:
Clinical Research Training in Schizophrenia and Other Psychoses
精神分裂症和其他精神病的临床研究培训
  • 批准号:
    10652592
  • 财政年份:
    2021
  • 资助金额:
    $ 90.37万
  • 项目类别:
Clinical Research Training in Schizophrenia and Other Psychoses
精神分裂症和其他精神病的临床研究培训
  • 批准号:
    10182926
  • 财政年份:
    2021
  • 资助金额:
    $ 90.37万
  • 项目类别:
Clinical Research Training in Schizophrenia and Other Psychoses
精神分裂症和其他精神病的临床研究培训
  • 批准号:
    10409777
  • 财政年份:
    2021
  • 资助金额:
    $ 90.37万
  • 项目类别:
Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode
在首次精神分裂症发作后通过锻炼加强认知训练
  • 批准号:
    9507959
  • 财政年份:
    2016
  • 资助金额:
    $ 90.37万
  • 项目类别:
Cognitive and Affective Dysfunctions in the Psychoses
精神病中的认知和情感功能障碍
  • 批准号:
    9393911
  • 财政年份:
    2016
  • 资助金额:
    $ 90.37万
  • 项目类别:
Enhancing Cognitive Training through Exercise after a First Schizophrenia Episode
第一次精神分裂症发作后通过锻炼加强认知训练
  • 批准号:
    8624560
  • 财政年份:
    2013
  • 资助金额:
    $ 90.37万
  • 项目类别:
Cognitive and Affective Dysfunctions in the Psychoses
精神病中的认知和情感功能障碍
  • 批准号:
    8475365
  • 财政年份:
    2013
  • 资助金额:
    $ 90.37万
  • 项目类别:
Enhancing Cognitive Training through Exercise after a First Schizophrenia Episode
第一次精神分裂症发作后通过锻炼加强认知训练
  • 批准号:
    8776334
  • 财政年份:
    2013
  • 资助金额:
    $ 90.37万
  • 项目类别:
Cognitive and Affective Dysfunctions in the Psychoses
精神病中的认知和情感功能障碍
  • 批准号:
    8653022
  • 财政年份:
    2013
  • 资助金额:
    $ 90.37万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 90.37万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 90.37万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 90.37万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 90.37万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 90.37万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 90.37万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 90.37万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 90.37万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 90.37万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 90.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了